These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 10963284

  • 21. A cost-effectiveness analysis of antibiotic therapy in macrolide-resistant community-acquired pneumonia.
    Earnshaw SR, Candrilli SD, Fernandes AW, Higashi MK.
    Manag Care Interface; 2005 Oct; 18(10):36-44. PubMed ID: 16265933
    [Abstract] [Full Text] [Related]

  • 22. A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium.
    Martin M, Moore L, Quilici S, Decramer M, Simoens S.
    Curr Med Res Opin; 2008 Mar; 24(3):737-51. PubMed ID: 18230196
    [Abstract] [Full Text] [Related]

  • 23. [Community-acquired Staphylococcus aureus pneumonia following influenza and the choice of empirical antibiotic treatment].
    van Nieuwkoop C, Bernards AT, Compier EA, Kraemer CV, Visser LG.
    Ned Tijdschr Geneeskd; 2008 Apr 05; 152(14):822-6. PubMed ID: 18491826
    [Abstract] [Full Text] [Related]

  • 24. Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia.
    File TM.
    Clin Infect Dis; 2004 Sep 01; 39 Suppl 3():S159-64. PubMed ID: 15546111
    [Abstract] [Full Text] [Related]

  • 25. [Efficacy and safety of clarithromycin in the treatment of community-acquired pneumonia].
    Parola D, Dell'Orso D, Terzano C.
    Recenti Prog Med; 2000 Jan 01; 91(1):12-5. PubMed ID: 10705778
    [Abstract] [Full Text] [Related]

  • 26. At the threshold: defining clinically meaningful resistance thresholds for antibiotic choice in community-acquired pneumonia.
    Daneman N, Low DE, McGeer A, Green KA, Fisman DN.
    Clin Infect Dis; 2008 Apr 15; 46(8):1131-8. PubMed ID: 18444846
    [Abstract] [Full Text] [Related]

  • 27. The role of new therapies for severe community-acquired pneumonia.
    Restrepo MI, Anzueto A.
    Curr Opin Infect Dis; 2006 Dec 15; 19(6):557-64. PubMed ID: 17075331
    [Abstract] [Full Text] [Related]

  • 28. [Antibiotherapy for acute CAP in adults].
    Denes E.
    Med Mal Infect; 2006 Dec 15; 36(11-12):718-33. PubMed ID: 17092678
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Diagnostic testing to establish a microbial cause is helpful in the management of community-acquired pneumonia.
    Skerrett SJ.
    Semin Respir Infect; 1997 Dec 15; 12(4):308-21. PubMed ID: 9436958
    [Abstract] [Full Text] [Related]

  • 31. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin.
    Kelley MA, Weber DJ, Gilligan P, Cohen MS.
    Clin Infect Dis; 2000 Oct 15; 31(4):1008-11. PubMed ID: 11049784
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.
    Yoo BK, Triller DM, Yong CS, Lodise TP.
    Ann Pharmacother; 2004 Oct 15; 38(7-8):1226-35. PubMed ID: 15187209
    [Abstract] [Full Text] [Related]

  • 34. Community-acquired pneumonia.
    Carbonara S, Monno L, Longo B, Angarano G.
    Curr Opin Pulm Med; 2009 May 15; 15(3):261-73. PubMed ID: 19387263
    [Abstract] [Full Text] [Related]

  • 35. Outpatient treatment of community-acquired pneumonia in adults.
    Pomilla PV, Brown RB.
    Arch Intern Med; 1994 Aug 22; 154(16):1793-802. PubMed ID: 8053746
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Emergency management of community-acquired bacterial pneumonia: what is new since the 2007 Infectious Diseases Society of America/American Thoracic Society guidelines.
    Moran GJ, Rothman RE, Volturo GA.
    Am J Emerg Med; 2013 Mar 22; 31(3):602-12. PubMed ID: 23380120
    [Abstract] [Full Text] [Related]

  • 38. Sparfloxacin: a review.
    Schentag JJ.
    Clin Ther; 2000 Apr 22; 22(4):372-87; discussion 371. PubMed ID: 10823360
    [Abstract] [Full Text] [Related]

  • 39. New antibiotics for community-acquired pneumonia.
    Kollef MH, Betthauser KD.
    Curr Opin Infect Dis; 2019 Apr 22; 32(2):169-175. PubMed ID: 30640820
    [Abstract] [Full Text] [Related]

  • 40. Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults.
    Drehobl MA, De Salvo MC, Lewis DE, Breen JD.
    Chest; 2005 Oct 22; 128(4):2230-7. PubMed ID: 16236879
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.